Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
4.910
-0.100 (-2.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $278.01 million as of February 21, 2025. Its market cap has increased by 115.84% in one year.
Market Cap
278.01M
Enterprise Value
26.46M
1-Year Change
115.84%
Ranking
Category
Stock Price
$4.91
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $278.01M, a decrease of -87.40%. That is a compound annual growth rate of -41.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 283.67M | -18.80% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |